Key facts
- Manuals
- 1
- Languages
- JA
- Last added
- 2023-11-03
Featured JCS/JHFS manuals

JCS/JHFS 2021 Guideline Focused Update on Diagnosis and Treatment of Acute and Chronic Heart Failure
This is the 2021 focused update of the JCS/JHFS guideline on the diagnosis and treatment of acute and chronic heart failure, revising the 2017 version. It begins with a chapter on definitions and classification, including heart failure types defined by left ventricular ejection fraction (HFrEF, HFpEF, HFmrEF) and by changes in ejection fraction over time (HFrecEF, HFworEF, HFuncEF), followed by a treatment algorithm.
Later chapters cover drug therapy (ivabradine as an If channel inhibitor, ARNI, SGLT2 inhibitors, and drugs for HFrEF), catheter-based treatment of mitral regurgitation with the MitraClip system, comorbid atrial fibrillation and renal failure, transcatheter aortic valve implantation and the Impella pump, and new drugs such as vericiguat and omecamtiv mecarbil. The document also explains how classes of recommendation, evidence levels and Minds grades are used. This manual is written in Japanese.
Covers: Definitions and classification of heart failure · LVEF-based classification (HFrEF, HFpEF, HFmrEF) · Treatment algorithm · Ivabradine (If channel inhibitor) · ARNI (angiotensin receptor neprilysin inhibitor) · SGLT2 inhibitors
Latest JCS/JHFS manuals
JCS/JHFS 2021 Guideline Focused Update on Diagnosis and Treatment of Acute and Chronic Heart Failure
Other 47 pages · 1.5 MB · JAFocused 2021 update of the JCS/JHFS heart failure guideline: LVEF classification, treatment algorithm, drug and device therapy, and evidence grading.
Questions answered in JCS/JHFS manuals
How does the guideline classify heart failure by LVEF?
It divides heart failure into HFrEF, HFpEF and HFmrEF according to left ventricular ejection fraction, with additional categories for changes in LVEF over time.
From: JCS/JHFS 2021 Guideline Focused Update on Diagnosis and Treatment of Acute and Chronic Heart Failure
What does ARNI stand for?
Angiotensin receptor neprilysin inhibitor.
From: JCS/JHFS 2021 Guideline Focused Update on Diagnosis and Treatment of Acute and Chronic Heart Failure
